-
Pharma CEO Series: An Evening with Robert Chess, Chairman of Nektar Therapeutics
6:30PM - 8:30PM Wed 7 Mar 2018, Pacific timezone
Rob Chess is Chairman of Nektar Therapeutics, (NASDAQ:NKTR), a health care biotechnology company developing new treatments for cancer, autoimmune diseases, and pain.
